Efficacy of topical tacrolimus for the treatment of persistent pruritus ani in patients with atopic dermatitis


Ucak H., Demir B., Cicek D., BAKAR DERTLİOĞLU S., Akkurt Z. M., Ucmak D., ...Daha Fazla

Journal of Dermatological Treatment, cilt.24, sa.6, ss.454-457, 2013 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 6
  • Basım Tarihi: 2013
  • Doi Numarası: 10.3109/09546634.2013.800181
  • Dergi Adı: Journal of Dermatological Treatment
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.454-457
  • Anahtar Kelimeler: anal itching, dermatology life quality index, eczema area and severity index, atopic dermatitis, pruritus ani, tacrolimus ointment
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: Pruritus ani (PA) is defined as intense chronic itching affecting perianal skin. Objective: We aimed to determine the efficacy of topical tacrolimus treatment in atopic dermatitis (AD) patients who have PA. Methods: The study included 32 patients with AD who were suffering PA. Patients were randomized into two groups. In total, 16 patients used 0.03% tacrolimus ointment and 16 patients used vaseline as placebo. All groups applied topical treatments to their perianal area twice daily for 4 weeks. The treatments were then reversed for 4 weeks after a 2 weeks wash out period. Results: In total, 32 patients with AD who had refractory anal itching were enrolled in this study. None of the patients had obtained successful results with previous treatments. There was a statistically significant decrease in the recorded EASI, DLQI and itching scores for the tacrolimus group compared to the placebo group at weeks 4 and 6 of treatment (p < 0.05). Conclusion: Topical tacrolimus treatment was well tolerated and effective in controlling persistent PA in AD patients. © 2013 Informa Healthcare USA on behalf of Informa UK Ltd.